Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ae2fbbd95296ad63c505160cc9be30f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9041b43ff34f7e21d151bb84bbcec12c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aacbbcb8667b06fcf2681b7862605f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0b29417a1039124b654e66188501f60 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6324869259b5797f8d26d01342e8abdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d7d7fad7ca858d9b558cd383ba1ac4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98204cb3c46305b3fefab8f7df590f81 |
publicationDate |
2014-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8709710-B2 |
titleOfInvention |
Methods of modulating interleukin-22 and immune response by notch regulators |
abstract |
The invention relates to the use of notch regulators for modulating IL-22 production in T-cells, by influencing the activity or activation of the notch signal path. The invention further relates to the use of modulating the immune response, primarily in case of infection reactions. The invention in particular relates to the use for treating illnesses associated with infections. The invention further relates to the use for reducing IL-22 production in T-cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944700-B2 |
priorityDate |
2009-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |